{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:14:08Z","timestamp":1751555648196},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1245\/s10434-021-10820-6","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T14:14:48Z","timestamp":1632924888000},"page":"935-944","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers"],"prefix":"10.1245","volume":"29","author":[{"given":"Masahiko","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihito","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Iwagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Tomimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eku","family":"Shimosegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"10820_CR1","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1200\/EDBK_160831","volume":"35","author":"JA Bridgewater","year":"2016","unstructured":"Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book. 2016;35:e194\u2013203.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10820_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ags3.12008","volume":"1","author":"H Colvin","year":"2017","unstructured":"Colvin H, Mizushima T, Eguchi H, Takiguchi S, Doki Y, Mori M. Gastroenterological surgery in Japan: the past, the present and the future. Ann Gastroenterol Surg. 2017;1(1):5\u201310.","journal-title":"Ann Gastroenterol Surg"},{"issue":"2","key":"10820_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1245\/s10434-014-4046-2","volume":"22","author":"T Yamamoto","year":"2015","unstructured":"Yamamoto T, Sugiura T, Mizuno T, Okamura Y, Aramaki T, Endo M, et al. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2015;22(2):677\u201384.","journal-title":"Ann Surg Oncol"},{"issue":"26","key":"10820_CR4","doi-asserted-by":"publisher","first-page":"e1037","DOI":"10.1097\/MD.0000000000001037","volume":"94","author":"BI Song","year":"2015","unstructured":"Song BI, Kim HW, Won KS, Ryu SW, Sohn SS, Kang YN. Preoperative standardized uptake value of metastatic lymph nodes measured by 18F-FDG PET\/CT improves the prediction of prognosis in gastric cancer. Medicine (Baltimore). 2015;94(26):e1037.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10820_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jso.21136","volume":"98","author":"J Li","year":"2008","unstructured":"Li J, Kuehl H, Grabellus F, Muller SP, Radunz S, Antoch G, et al. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET\/CT. J Surg Oncol. 2008;98(6):438\u201343.","journal-title":"J Surg Oncol."},{"issue":"12","key":"10820_CR6","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s00330-008-1062-2","volume":"18","author":"H Furukawa","year":"2008","unstructured":"Furukawa H, Ikuma H, Asakura-Yokoe K, Uesaka K. Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology. Eur Radiol. 2008;18(12):2841\u20137.","journal-title":"Eur Radiol"},{"issue":"5","key":"10820_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1572-0241.2007.01710.x","volume":"103","author":"JY Kim","year":"2008","unstructured":"Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103(5):1145\u201351.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10820_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","volume":"45","author":"H Petrowsky","year":"2006","unstructured":"Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, et al. impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45(1):43\u201350.","journal-title":"J Hepatol"},{"issue":"1","key":"10820_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","volume":"8","author":"CD Anderson","year":"2004","unstructured":"Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8(1):90\u20137.","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10820_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1440-1746.2007.05173.x","volume":"23","author":"CM Moon","year":"2008","unstructured":"Moon CM, Bang S, Chung JB, Park SW, Song SY, Yun M, et al. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol. 2008;23(5):759\u201365.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10820_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/MNM.0b013e3282f1ac85","volume":"28","author":"Y Nishiyama","year":"2007","unstructured":"Nishiyama Y, Yamamoto Y, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, et al. Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nucl Med Commun. 2007;28(12):914\u20139.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10820_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jso.21811","volume":"103","author":"S Kobayashi","year":"2011","unstructured":"Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, et al. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol. 2011;103(3):223\u20139.","journal-title":"J Surg Oncol"},{"issue":"5","key":"10820_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jso.21501","volume":"101","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi S, Nagano H, Marubashi S, Wada H, Eguchi H, Takeda Y, et al. Multidetector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer. J Surg Oncol. 2010;101(5):376\u201383.","journal-title":"J Surg Oncol"},{"issue":"3","key":"10820_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jhbp.211","volume":"22","author":"M Miyazaki","year":"2015","unstructured":"Miyazaki M, Ohtsuka M, Miyakawa S, Nagino M, Yamamoto M, Kokudo N, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3 (rd) English edition. J Hepatobiliary Pancreat Sci. 2015;22(3):181\u201396.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"Suppl 8","key":"10820_CR15","first-page":"VIII20","volume":"29","author":"D Sakai","year":"2018","unstructured":"Sakai D, Kanai M, Kobayashi S, Eguchi H, Baba H, Seo S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA). Ann Oncol. 2018;29(Suppl 8):VIII20.","journal-title":"Ann Oncol."},{"issue":"12","key":"10820_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1097\/JTO.0000000000000689","volume":"10","author":"HY Lee","year":"2015","unstructured":"Lee HY, Lee SW, Lee KS, Jeong JY, Choi JY, Kwon OJ, et al. Role of CT and PET imaging in predicting tumor recurrence and survival in patients with lung adenocarcinoma: a comparison with the International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society Classification of Lung Adenocarcinoma. J Thorac Oncol. 2015;10(12):1785\u201394.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10820_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/MNM.0b013e32833823ac","volume":"31","author":"H Alakus","year":"2010","unstructured":"Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallbohmer D, et al. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun. 2010;31(6):532\u20138.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10820_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1590\/S1807-59322011000600008","volume":"66","author":"KC Carvalho","year":"2011","unstructured":"Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaiba MM, Begnami MD, et al. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo). 2011;66(6):965\u201372.","journal-title":"Clinics (Sao Paulo)"},{"issue":"9","key":"10820_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/BF02984657","volume":"20","author":"A Yamada","year":"2006","unstructured":"Yamada A, Oguchi K, Fukushima M, Imai Y, Kadoya M. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med. 2006;20(9):597\u2013604.","journal-title":"Ann Nucl Med"},{"issue":"8","key":"10820_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.humpath.2014.03.008","volume":"45","author":"Y Kubo","year":"2014","unstructured":"Kubo Y, Aishima S, Tanaka Y, Shindo K, Mizuuchi Y, Abe K, et al. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma. Hum Pathol. 2014;45(8):1610\u20137.","journal-title":"Hum Pathol"},{"issue":"3","key":"10820_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00268-017-4192-3","volume":"42","author":"KW Ma","year":"2018","unstructured":"Ma KW, Cheung TT, She WH, Chok KSH, Chan ACY, Dai WC, et al. Diagnostic and Prognostic role of 18-FDG PET\/CT in the management of resectable biliary tract cancer. World J Surg. 2018;42(3):823\u201334.","journal-title":"World J Surg"},{"issue":"2","key":"10820_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00280-014-2648-9","volume":"75","author":"M Kanai","year":"2015","unstructured":"Kanai M, Hatano E, Kobayashi S, Fujiwara Y, Marubashi S, Miyamoto A, et al. A multi-institution phase II study of gemcitabine\/cisplatin\/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002). Cancer Chemother Pharmacol. 2015;75(2):293\u2013300.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10820-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10820-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10820-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:15:27Z","timestamp":1641222927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10820-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10820"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10820-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Masahiko Kubo, Shogo Kobayashi, Kunihito Gotoh, Hirotoshi Takayama, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Takehiro Noda, Hiroki Kato, Eku Shimosegawa, Yuichiro Doki, and Hidetoshi Eguchi have declared no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}